Status at end of treatment in 416 patients according to initial drug susceptibility profile (Intent – to –treat analysis).

*Response could not be assessed in 7 lost patients – Gatifloxacin (4), Moxifloxacin (1), Control (2).∧4 patients –Treatment changed for toxicity (Seizure - 3, Cardiac –1), unfavouable bacteriological response –3.@ Treatment changed for pneumothorax −1, unfavouable bacteriological response −1.$ Treatment changed for hepatotoxicity –1, unfavouable bacteriological response −4.7例失访患者的疗效无法评估——其中加替沙星（Gatifloxacin）组4例、莫西沙星（Moxifloxacin）组1例、对照组（Control）2例。4例患者因不良反应调整治疗方案：3例因癫痫发作、1例因心脏不良反应，另有3例细菌学应答不佳。1例因气胸调整治疗方案，1例细菌学应答不佳。1例因肝毒性调整治疗方案，4例细菌学应答不佳。